Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ester Simeone

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Journal of Translational Medicine|May 30, 2012
Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical usePaolo A Ascierto, Ester Simeone, Diana Giannarelli, et al.
Discovery Medicine|July 16, 2015
Novel mechanisms and therapeutic approaches in melanoma: targeting the MAPK pathwayAntonio Maria Grimaldi, Ester Simeone, Lucia Festino, et al.
Oncoimmunology|January 4, 2018
PD-L1 inhibitors in the pipeline: Promise and progressVito Vanella, Lucia Festino, Martina Strudel, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 7, 2017
Combination Treatment of Patients with BRAF-Mutant Melanoma: A New Standard of CareEster Simeone, Antonio M Grimaldi, Lucia Festino, et al.
American Journal of Clinical Dermatology|May 25, 2017
MEK Inhibitors in the Treatment of Metastatic Melanoma and Solid TumorsAntonio M Grimaldi, Ester Simeone, Lucia Festino, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2016
Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trialPaolo A Ascierto, Vito Vanella, Antonio Maria Grimaldi, et al.
Critical Reviews in Oncology/Hematology|July 2, 2005
Adjuvant treatment of malignant melanoma: where are we?Paolo A Ascierto, Stefania Scala, Alessandro Ottaiano, et al.
Journal of Translational Medicine|March 19, 2013
Do BRAF inhibitors select for populations with different disease progression kinetics?Paolo Antonio Ascierto, Ester Simeone, Antonio Maria Grimaldi, et al.
Cytojournal|July 5, 2007
Nevoid melanoma of the vagina: report of one case diagnosed on thin layer cytological preparationsFranco Fulciniti, Paolo Antonio Ascierto, Ester Simeone, et al.
Journal of Medical Case Reports|July 3, 2014
Serious haematological toxicity during and after ipilimumab treatment: a case seriesEster Simeone, Antonio Maria Grimaldi, Assunta Esposito, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Journal of Translational Medicine|May 30, 2012
Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical usePaolo A Ascierto, Ester Simeone, Diana Giannarelli, et al.
Discovery Medicine|July 16, 2015
Novel mechanisms and therapeutic approaches in melanoma: targeting the MAPK pathwayAntonio Maria Grimaldi, Ester Simeone, Lucia Festino, et al.
Oncoimmunology|January 4, 2018
PD-L1 inhibitors in the pipeline: Promise and progressVito Vanella, Lucia Festino, Martina Strudel, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 7, 2017
Combination Treatment of Patients with BRAF-Mutant Melanoma: A New Standard of CareEster Simeone, Antonio M Grimaldi, Lucia Festino, et al.
American Journal of Clinical Dermatology|May 25, 2017
MEK Inhibitors in the Treatment of Metastatic Melanoma and Solid TumorsAntonio M Grimaldi, Ester Simeone, Lucia Festino, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2016
Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trialPaolo A Ascierto, Vito Vanella, Antonio Maria Grimaldi, et al.
Critical Reviews in Oncology/Hematology|July 2, 2005
Adjuvant treatment of malignant melanoma: where are we?Paolo A Ascierto, Stefania Scala, Alessandro Ottaiano, et al.
Journal of Translational Medicine|March 19, 2013
Do BRAF inhibitors select for populations with different disease progression kinetics?Paolo Antonio Ascierto, Ester Simeone, Antonio Maria Grimaldi, et al.
Cytojournal|July 5, 2007
Nevoid melanoma of the vagina: report of one case diagnosed on thin layer cytological preparationsFranco Fulciniti, Paolo Antonio Ascierto, Ester Simeone, et al.
Journal of Medical Case Reports|July 3, 2014
Serious haematological toxicity during and after ipilimumab treatment: a case seriesEster Simeone, Antonio Maria Grimaldi, Assunta Esposito, et al.
Pageof 10